Currently holds a position at Opiant Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Independent Director | Opiant Pharmaceuticals Inc | Oct. 29, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-09-27 | 2022-09-23 |
Terrascend Corp
(TER)
|
B Purchase |
60,000
0.000 USD |
60,000 | 0.00 | 0 USD | |
2022-09-26 | 2022-09-22 |
Terrascend Corp
(TER)
|
B Purchase |
120,000
0.000 USD |
120,000 | 0.00 | 0 USD | |
2022-06-13 | 2022-06-10 |
Opiant Pharmaceuticals Inc
(OPNT)
|
B Purchase |
1,663
+3.5%
11.5019,118 USD |
1,663 +3.5% | 11.50 | 19,118 USD | |
2022-05-17 | 2022-05-16 |
Opiant Pharmaceuticals Inc
(OPNT)
|
B Purchase |
27,150
+129.5%
13.54367,611 USD |
27,150 +129.5% | 13.54 | 367,611 USD | |
2022-05-16 | 2022-05-13 |
Opiant Pharmaceuticals Inc
(OPNT)
|
B Purchase |
3,689
+21.3%
10.4938,698 USD |
3,689 +21.3% | 10.49 | 38,698 USD | |
2021-11-24 | 2021-11-24 |
Sierra Oncology Inc
(SRRA)
|
B Purchase |
7,899
+141.0%
23.09182,348 USD |
7,899 +141.0% | 23.09 | 182,348 USD | |
2021-11-24 | 2021-11-23 |
Sierra Oncology Inc
(SRRA)
|
B Purchase |
5,601
+inf%
22.95128,515 USD |
5,601 +inf% | 22.95 | 128,515 USD | |
2021-09-13 | 2021-09-10 |
Opiant Pharmaceuticals Inc
(OPNT)
|
B Purchase |
9,577
+239.4%
18.18174,110 USD |
9,577 +239.4% | 18.18 | 174,110 USD |